These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37260698)

  • 1. High-sensitivity HBV DNA test for the diagnosis of occult HBV infection: commonly used but not reliable.
    Wang C; Xue R; Wang X; Xiao L; Xian J
    Front Cell Infect Microbiol; 2023; 13():1186877. PubMed ID: 37260698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: A new tool to detect occult infection.
    Caviglia GP; Abate ML; Tandoi F; Ciancio A; Amoroso A; Salizzoni M; Saracco GM; Rizzetto M; Romagnoli R; Smedile A
    J Hepatol; 2018 Aug; 69(2):301-307. PubMed ID: 29621551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No Cirrhosis.
    Wong DK; Cheng SCY; Mak LL; To EW; Lo RC; Cheung TT; Seto WK; Fung J; Man K; Lai CL; Yuen MF
    Clin Gastroenterol Hepatol; 2020 Feb; 18(2):449-456. PubMed ID: 31252193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Occult hepatitis B virus infection: transmission and reactivation].
    Song SH; Hwang SG
    Korean J Gastroenterol; 2013 Sep; 62(3):148-53. PubMed ID: 24077624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occult Hepatitis B Virus Infection: An Update.
    Saitta C; Pollicino T; Raimondo G
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and Serological Characterization of Hepatitis B Virus (HBV)-Positive Samples with Very Low or Undetectable Levels of HBV Surface Antigen.
    Kuhns MC; Holzmayer V; Anderson M; McNamara AL; Sauleda S; Mbanya D; Duong PT; Dung NTT; Cloherty GA
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of HBV cccDNA in occult hepatitis B virus infection.
    He P; Zhang P; Fang Y; Han N; Yang W; Xia Z; Zhu Y; Zhang Z; Shen J
    Mol Cell Biochem; 2023 Oct; 478(10):2297-2307. PubMed ID: 36735210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significance.
    Mak LY; Wong DK; Pollicino T; Raimondo G; Hollinger FB; Yuen MF
    J Hepatol; 2020 Oct; 73(4):952-964. PubMed ID: 32504662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence of viral hepatitis B markers among blood donors in the Republic of Guinea].
    Boumbaly S; Balde TAL; Semenov AV; Ostankova YV; Serikova EN; Naidenova EV; Valutite DE; Shchemelev AN; Zueva EB; Esaulenko EV; Totolian AA
    Vopr Virusol; 2022 Mar; 67(1):59-68. PubMed ID: 35293189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of occult hepatitis B virus infection: an update for the clinician.
    Lledó JL; Fernández C; Gutiérrez ML; Ocaña S
    World J Gastroenterol; 2011 Mar; 17(12):1563-8. PubMed ID: 21472122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occult hepatitis B virus infection: implications in transfusion.
    Allain JP
    Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of occult hepatitis B virus infection in chronic hepatitis C.
    Coppola N; Onorato L; Pisaturo M; Macera M; Sagnelli C; Martini S; Sagnelli E
    World J Gastroenterol; 2015 Nov; 21(42):11931-40. PubMed ID: 26576082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological and Molecular Diagnosis of Occult Hepatitis B Virus Infection in Hepatitis C Chronic Liver Diseases.
    Daef EA; Makhlouf NA; Ahmed EH; Mohamed AI; Abd El Aziz MH; El-Mokhtar MA
    Egypt J Immunol; 2017 Jan; 24(1):37-48. PubMed ID: 29120576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occult hepatitis B virus infection among patients with chronic liver disease of unidentified cause, Addis Ababa Ethiopia.
    Gissa SB; Minaye ME; Yeshitela B; Gemechu G; Tesfaye A; Alemayehu DH; Shewaye A; Sultan A; Mihret A; Mulu A
    Sci Rep; 2022 Aug; 12(1):13188. PubMed ID: 35915105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological study of occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma.
    El-Maksoud MA; Habeeb MR; Ghazy HF; Nomir MM; Elalfy H; Abed S; Zaki MES
    Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):716-722. PubMed ID: 30870221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virological characteristics of occult hepatitis B virus in a North American cohort of human immunodeficiency virus type 1-positive patients on dual active anti-HBV/HIV therapy.
    Coffin CS; Mulrooney-Cousins PM; Osiowy C; van der Meer F; Nishikawa S; Michalak TI; van Marle G; Gill MJ
    J Clin Virol; 2014 Aug; 60(4):347-53. PubMed ID: 24881491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of occult hepatitis B virus infection.
    Lalana Garcés M; Ortiz Pastor O; Solé Enrech G; Guerra-Ruiz AR; Casals Mercadal G; Almería Lafuente A; Ballesteros Vizoso MA; Medina PG; Salgüero Fernández S; Zamora Trillo A; Aured de la Serna I; Hurtado JC; Pérez-Del-Pulgar S; Forns X; Morales Ruiz M
    Adv Lab Med; 2022 Dec; 3(4):321-341. PubMed ID: 37363431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occult HBV infection.
    Raimondo G; Caccamo G; Filomia R; Pollicino T
    Semin Immunopathol; 2013 Jan; 35(1):39-52. PubMed ID: 22829332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and chemotherapy-induced reactivation of occult hepatitis B virus among hepatitis B surface antigen negative patients with diffuse large B-cell lymphoma: significance of hepatitis B core antibodies screening.
    Elbedewy TA; Elashtokhy HE; Rabee ES; Kheder GE
    J Egypt Natl Canc Inst; 2015 Mar; 27(1):11-8. PubMed ID: 25716703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the clinical impact of occult HBV infections and anti-HBc positivity in patients with chronic hepatitis C?
    Cakal B; Cavus B; Atasoy A; Poda M; Bulakci M; Gulluoglu M; Demirci M; Sener LT; Altunok D; Arslan AB; Akyuz F
    Microbiol Immunol; 2022 Aug; 66(8):386-393. PubMed ID: 35661243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.